InvestorsHub Logo
Followers 2662
Posts 8617
Boards Moderated 0
Alias Born 11/08/2012

Re: None

Saturday, 12/29/2012 2:10:13 PM

Saturday, December 29, 2012 2:10:13 PM

Post# of 130504
ENGLISH prof. analayed latest 8K on 12-28-12...READ
On 8 November 2012, Amarantus BioScience, Inc. issued a press release indicating that data stemming from its research grant from the Michael J. Fox Foundation would be released to the public in December 2012. The Company has decided to withhold the release of the data until January 8th, 2013 at 1:40pm Pacific time, when the Company’s Chief Scientific Officer Dr. John W. Commissiong will present the data at the OneMedForum 2013 at the Sir Francis Drake Hotel in San Francisco, CA. The presentation will be made available online at. The cause for the delay is the Company is conferring with leading academics and collaborators to confirm various aspects of the data results in order to ensure complete accuracy and transparency. The Company believes confirmation of the results with leaders in the field prior to release to the public is in the best interests of its shareholders.

The studies have uncovered more profound reults than originally expected. The results go beyond what was originally intended that is the reason to have other scientists research further.

Final statement states to (ENSURE) guarantee the results.

Common sense would dictate to ensure shareholder value would not mean devalue the stock...HO HO HO.